Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2026-02-03 @ 5:56 AM
Study NCT ID:
NCT03944902
Status:
TERMINATED
Last Update Posted:
2023-11-21
First Post:
2019-05-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CB-839 in Combination With Niraparib in Platinum Resistant BRCA -Wild-type Ovarian Cancer Patients
Sponsor:
University of Alabama at Birmingham
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-05
Completion Date Type:
ACTUAL
First Submit Date:
2019-05-01
First Submit QC Date:
None
Study First Post Date:
2019-05-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-17
Last Update Post Date:
2023-11-21
Last Update Post Date Type:
ACTUAL